Max Healthcare Institute Management
Management criteria checks 3/4
Max Healthcare Institute's CEO is Abhay Soi, appointed in Jun 2020, has a tenure of 3.83 years. total yearly compensation is ₹140.00M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 23.75% of the company’s shares, worth ₹185.30B. The average tenure of the management team and the board of directors is 4.5 years and 3.3 years respectively.
Key information
Abhay Soi
Chief executive officer
₹140.0m
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 3.8yrs |
| CEO ownership | 23.7% |
| Management average tenure | 4.5yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today
Apr 14
Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors
Mar 18Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly
Jan 08Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable
Dec 18With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Sep 20Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?
Jul 07Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Jun 19Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now
Apr 11With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Mar 15Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Feb 22Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet
Nov 22Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly
Jul 15Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly
Mar 09Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals
Nov 24Is Max Healthcare Institute (NSE:MAXHEALTH) Using Too Much Debt?
Jul 24Max Healthcare Institute Limited (NSE:MAXHEALTH) Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates
Jun 01Have Insiders Been Buying Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares This Year?
Feb 21What Percentage Of Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares Do Insiders Own?
Jan 16
We Think Max Healthcare Institute (NSE:MAXHEALTH) Is Taking Some Risk With Its Debt
Dec 20Who Has Been Buying Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares?
Nov 15What Type Of Shareholders Own The Most Number of Max Healthcare Institute Limited (NSE:MAXHEALTH) Shares?
Oct 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹11b |
| Sep 30 2023 | n/a | n/a | ₹10b |
| Jun 30 2023 | n/a | n/a | ₹12b |
| Mar 31 2023 | ₹140m | ₹140m | ₹11b |
| Dec 31 2022 | n/a | n/a | ₹10b |
| Sep 30 2022 | n/a | n/a | ₹9b |
| Jun 30 2022 | n/a | n/a | ₹6b |
| Mar 31 2022 | ₹140m | ₹49m | ₹6b |
| Dec 31 2021 | n/a | n/a | ₹6b |
| Sep 30 2021 | n/a | n/a | ₹5b |
| Jun 30 2021 | n/a | n/a | ₹3b |
| Mar 31 2021 | ₹117m | ₹91m | -₹1b |
Compensation vs Market: Abhay's total compensation ($USD1.68M) is above average for companies of similar size in the Indian market ($USD599.06K).
Compensation vs Earnings: Abhay's compensation has been consistent with company performance over the past year.
CEO
Abhay Soi (50 yo)
3.8yrs
Tenure
₹140,000,000
Compensation
Mr. Abhay Soi is a Co-Founder of Halcyon Group. He served as Executive Officer at Ernst & Young LLP. Mr. Soi served as Head of Financial Restructuring group at Ernst & Young and Arthur Anderson.He has in-...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 3.8yrs | ₹140.00m | 23.75% ₹ 185.3b | |
| Senior Director & CFO | 12.3yrs | ₹41.90m | 0.0062% ₹ 48.1m | |
| Senior VP | 1.2yrs | ₹1.70m | no data | |
| Senior Director of Operations & Planning and COO of Cluster 1 | no data | no data | no data | |
| Director of Information Technology & Chief Information Officer | 4.6yrs | no data | no data | |
| Director of Legal & Regulatory Affairs | no data | no data | no data | |
| Senior Director and Chief Sales & Marketing Officer | no data | no data | no data | |
| Senior Director - HR & Chief People Officer | 4.7yrs | no data | no data | |
| Chairman of MAMBS | no data | ₹4.42m | no data | |
| Chairman and Chief Surgeon of Orthopaedics & Joint Replacement | 4.5yrs | no data | no data | |
| Chairman of Paediatrics & Paediatric Surgery | 3.3yrs | no data | no data | |
| Chairperson of Max Institute of Cancer Care | 5.2yrs | no data | no data |
4.5yrs
Average Tenure
54.5yo
Average Age
Experienced Management: MAXHEALTH's management team is considered experienced (4.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 4.8yrs | ₹140.00m | 23.75% ₹ 185.3b | |
| Director & Chief Procurement Officer | no data | no data | no data | |
| Independent Director | 14.7yrs | ₹4.80m | 0.00051% ₹ 4.0m | |
| Non-Executive Independent Director | 1.7yrs | ₹2.20m | no data | |
| Non-Executive Independent Director | 4.8yrs | ₹4.80m | no data | |
| Non-Executive Non-Independent Director | less than a year | no data | no data | |
| Non-Executive Independent Woman Director | less than a year | no data | no data | |
| Non-Executive Independent Director | 4.8yrs | ₹4.30m | no data | |
| Non-Executive Non-Independent Director | 1.7yrs | ₹2.20m | no data |
3.3yrs
Average Tenure
61yo
Average Age
Experienced Board: MAXHEALTH's board of directors are considered experienced (3.3 years average tenure).